Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 19, 2023

Primary Completion Date

June 19, 2023

Study Completion Date

August 22, 2023

Conditions
Pneumonia, AspirationAnesthesia
Interventions
DRUG

semaglutide use

patient using semaglutide for at least 7 days

Trial Locations (1)

05652900

Hospital Israelita Albert Einstein, São Paulo

All Listed Sponsors
lead

Hospital Israelita Albert Einstein

OTHER

NCT06154486 - Evaluation of Gastric Content of Volunteers Fasting and Using Semaglutide: an Observational and Cross-sectional Study | Biotech Hunter | Biotech Hunter